Increased Occurrence of Malignancy Before and after Chemoradiation for Anal Squamous Cell Carcinoma: A Multi-Institutional Analysis

Head and Neck Cancer

Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis

Clin Cancer Res

Saba NF, Chaudhary R, Kirtane K, Marra A, Ekpenyong A, McCook-Veal A, Schmitt NC, Gross JH, Patel MR, Remick J, Bates JE, McDonald MW, Rudra SF, Stokes WA, Biernacki M, Song X, Slebos RJC, Liu Y, Steuer CE, Shin DM, Teng Y, Chung CH

doi: 10.1158/1078-0432.CCR-24-1202

Head and Neck Cancer

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis

Lancet Oncol

Gharzai LA, Morris E, Suresh K, Nguyen-Tân PF, Rosenthal DI, Gillison ML, Harari PM, Garden AS, Koyfman S, Caudell JJ, Jones CU, Mitchell DL, Krempl G, Ridge JA, Gensheimer MF, Bonner JA, Filion E, Dunlap NE, Stokes WA, Le QT, Torres-Saavedra P, Mierzwa M, Schipper MJ

doi: 10.1016/S1470-2045(24)00016-0

Gastrointestinal Cancer

Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline

J Clin Oncol

Morris VK, Kennedy EB, Amin MA, Aranha O, Benson AB 3rd, Dorth JA, Horowitz DP, Kennecke HF, Kim S, Kreppel L, Mettu NB, Rajdev L, Riechelmann R, Sio TT, Eng C

doi: 10.1200/JCO-24-02120

Genitourinary Cancer

The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Cancer Treat Rev

Zhang Y, Chen J, Liu H, Dai J, Zhao J, Zhu S, Zhang X, Liang J, Hu X, Zhao J, Liu Z, Shen P, Sun G, Zeng H

doi: 10.1016/j.ctrv.2024.102787

Head and Neck Cancer

A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies

Cancer Treat Rev

Jiménez-Labaig P, Rullan A, Hernando-Calvo A, Llop S, Bhide S, O'Leary B, Braña I, Harrington KJ

doi: 10.1016/j.ctrv.2024.102772

Further Publications

Treatment of Stages I-III Squamous Cell Anal Cancer: A Comparative Effectiveness Systematic Review

J Natl Cancer Inst

Troester A, Parikh R, Southwell B, Ester E, Sultan S, Greeno E, Arsoniadis E, Church TR, Wilt T, Butler M, Goffredo P

doi: 10.1093/jnci/djae195

Further Publications

Second primary malignancies after CAR T-cell therapy: A systematic review and meta-analysis of 5,517 lymphoma and myeloma patients

Clin Cancer Res

Tix T, Alhomoud M, Shouval R, Cliff ERS, Perales MA, Cordas Dos Santos DM, Rejeski K

doi: 10.1158/1078-0432.CCR-24-1798

Radio-Oncology

Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation

Lancet Oncol

Lichter KE, Charbonneau K, Lewy JR, Bloom JR, Shenker R, Sabbagh A, Chino J, Rodrigues A, Hearn J, Grover S, Sheu RD, Witztum A, Qureshi MM, Yom SS, Anand C, Thiel CL, Mohamad O

doi: 10.1016/S1470-2045(24)00148-7

Head and Neck Cancer

Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma

J Cancer Res Clin Oncol

Huwyler F, Giger R, Bill R, Rauch D, Haefliger S

doi: 10.1007/s00432-024-06044-2

Related content

Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis

Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline

The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies

Treatment of Stages I-III Squamous Cell Anal Cancer: A Comparative Effectiveness Systematic Review

Second primary malignancies after CAR T-cell therapy: A systematic review and meta-analysis of 5,517 lymphoma and myeloma patients

Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation

Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma